KLF16 Promotes Proliferation in Gastric Cancer Cells Via Regulating P21 and CDK4.

Pei Ma,Chong-Qi Sun,Yan-Fen Wang,Yu-Tian Pan,Qin-Nan Chen,Wei-Tao Liu,Jie Liu,Chen-Hui Zhao,Yong-Qian Shu,Wei Li
2017-01-01
Abstract:Krüppel-like factors (KLFs), such as KLF4, KLF2, KLF5 and KLF15, have been extensively investigated in multi-cancers. However, KLF16, a member of KLFs, hasn't been well identified in cancer, especially in gastric cancer (GC). Here, we investigated the roles of KLF16 in GC. In present study, we found that KLF16 expression levels were significantly up-regulated in GC tissues compared to adjacent normal tissues both in protein and mRNA levels by using immunohistochemistry assays (IHC) and real-time quantitative PCR (qPCR). And KLF16 expression levels were positively correlated to tumor size, invasion depth, lymphatic metastasis and TNM stage. Furthermore, KLF16 expression also could predict prognosis in patients with GC. Moreover, the knock-down of KLF16 could significantly suppress proliferation via increasing p21 expression and decreasing CDK4 expression in GC cell lines. In summary, these findings demonstrate that KLF16 plays a significant role in GC progression and could be a new therapeutic target for GC patients.
What problem does this paper attempt to address?